文献速递临床试验与 GCP真实世界研究与卫生经济

通过社区参与系统应对秘鲁普诺的高血压与糖尿病(ANDES):2型混合效果与实施随机对照试验的原理与研究方案

Addressing Hypertension and Diabetes through Community-Engaged Systems (ANDES) in Puno, Peru: rationale and study protocol for a hybrid type 2 effectiveness and implementation randomized controlled trial.
PubMed 文献 · Trials · 2024-11-09

ANDES试验将在秘鲁普诺招募1068名≥18岁高血压成人,1:1随机分为常规照护组或接受为期12个月的社区健康工作者主导的家庭高血压控制项目,该项目包括血压监测、用药依从性支持和健康生活方式咨询。主要临床效果结局为收缩压平均变化,同时评估实施保真度、覆盖、采纳、可持续性、可接受性和成本效果。

要点

  • 试验在秘鲁普诺国家初级保健系统内评估社区健康工作者主导的高血压控制项目。
  • 纳入1068名≥18岁高血压成人,1:1随机分为常规照护组与12个月社区健康工作者家庭干预组。
  • 主要结局为收缩压平均变化,同时评估实施结局与成本效果。

核心结论

  • ANDES试验正在测试秘鲁首个由社区健康工作者主导的多组分高血压和2型糖尿病管理策略,该2型混合试验将为成功实施和效果所需的个体、社区和系统层面因素提供关键见解。

研究设计与样本

  • 2型混合效果与实施随机对照试验,计划在秘鲁普诺通过机构招募和社区健康博览会招募1068名≥18岁高血压成人,个体1:1随机分为常规照护组或12个月社区健康工作者主导的家庭高血压控制项目组。

主要发现

  • 临床效果结局包括收缩压平均变化(主要结局)、舒张压和HbA1C。
  • 实施结局包括保真度(即社区健康工作者方案依从性和剂量)、覆盖、采纳、可持续性、可接受性和成本效果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertension is the most common cardiovascular disease in Peru despite the availability of cost-effective, evidence-based treatment. Here we describe the rationale and study design for a hybrid type 2 randomized controlled trial to test the implementation and effectiveness of a community health worker (CHW)-led hypertension control program within the national primary care system in Puno, Peru. METHODS: We will recruit 1068 adult participants with hypertension aged ≥ 18 years in Puno, Peru, via facility-based enrollment and community health fairs. Participants will be individually randomized (1:1) to either continue with usual care or participate in a 12-month CHW-led home-based hypertension control program consisting of blood pressure monitoring, medication adherence support, and healthy lifestyle counseling. Outcome development and reporting are guided by the Consolidated Framework for Implementation Research (CFIR), the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework, and the Proctor et al. framework. Clinical effectiveness outcomes include mean change in systolic blood pressure (primary outcome), diastolic blood pressure, and HbA1C. Implementation outcomes include fidelity (i.e., CHW protocol adherence and dose), reach, adoption, sustainability, acceptability, and cost-effectiveness. DISCUSSION: The ANDES trial is testing the first CHW-led multicomponent strategy for hypertension and type 2 diabetes management in Peru. This type 2 hybrid trial will provide critical insights into the individual, community, and system-level factors necessary for successful implementation and effectiveness. These data can inform the future adaptation and scaling of the ANDES strategy in Peru and other LMICs, as well as influence policies at the system level to support this transition. Furthermore, by addressing both hypertension and diabetes, the ANDES strategy supports integrated care approaches advocated by the WHO HEARTS technical package, ultimately enhancing health outcomes and reducing morbidity and mortality in the region. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT05524987 , Addressing Hypertension and Diabetes through Community-Engaged Systems in Puno, Peru (ANDES study), prospectively registered on September 1, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Underhill LJ, Williams KN, Cordova-Ascona L, et al. Addressing Hypertension and Diabetes through Community-Engaged Systems (ANDES) in Puno, Peru: rationale and study protocol for a hybrid type 2 effectiveness and implementation randomized controlled trial. Trials. 2024. PMID: 39516847. doi:10.1186/s13063-024-08586-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。